BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29771752)

  • 1. Radiotherapy for Active Thyroid Eye Disease.
    Godfrey KJ; Kazim M
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S98-S104. PubMed ID: 29771752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orbital Radiotherapy Combined With Corticosteroid Treatment for Thyroid Eye Disease-Compressive Optic Neuropathy.
    Gold KG; Scofield S; Isaacson SR; Stewart MW; Kazim M
    Ophthalmic Plast Reconstr Surg; 2018; 34(2):172-177. PubMed ID: 29517594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
    Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose orbital radiotherapy for thyroid eye disease.
    Li Yim JF; Sandinha T; Kerr JM; Ritchie D; Kemp EG
    Orbit; 2011 Dec; 30(6):269-74. PubMed ID: 22132844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital radiotherapy for thyroid eye disease.
    Dolman PJ; Rath S
    Curr Opin Ophthalmol; 2012 Sep; 23(5):427-32. PubMed ID: 22729183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital Radiation Therapy in Thyroid Eye Disease.
    Chundury RV; Weber AC; Perry JD
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):83-9. PubMed ID: 26325378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute thyroid eye disease (TED): principles of medical and surgical management.
    Verity DH; Rose GE
    Eye (Lond); 2013 Mar; 27(3):308-19. PubMed ID: 23412559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid eye disease: therapy in the active phase.
    Bhatti MT; Dutton JJ
    J Neuroophthalmol; 2014 Jun; 34(2):186-97. PubMed ID: 24821102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
    Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
    J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for the treatment of thyroid eye disease-a prospective comparison: Is orbital radiotherapy a suitable alternative to steroids?
    Grassi P; Strianese D; Piscopo R; Pacelli R; Bonavolontà G
    Ir J Med Sci; 2017 Aug; 186(3):647-652. PubMed ID: 28050807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.
    Sisti E; Menconi F; Leo M; Profilo MA; Mautone T; Mazzi B; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2015 Jun; 38(6):661-8. PubMed ID: 25596664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital radiotherapy in the management of Graves' orbitopathy--current state of knowledge.
    Ruchała M; Hernik A; Zybek A
    Endokrynol Pol; 2014; 65(5):388-96. PubMed ID: 25301490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease.
    Claridge KG; Ghabrial R; Davis G; Tomlinson M; Goodman S; Harrad RA; Potts MJ
    Eye (Lond); 1997; 11 ( Pt 5)():717-22. PubMed ID: 9474324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology.
    Sobel RK; Aakalu VK; Vagefi MR; Foster JA; Tao JP; Freitag SK; Wladis EJ; McCulley TJ; Yen MT
    Ophthalmology; 2022 Apr; 129(4):450-455. PubMed ID: 34895729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease.
    Ayabe R; Rootman DB; Hwang CJ; Ben-Artzi A; Goldberg R
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):415-9. PubMed ID: 24978425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy for Graves' ophthalmopathy: a systematic review and meta-analysis of randomized controlled trials.
    Viani GA; Boin AC; De Fendi LI; Fonseca EC; Stefano EJ; Paula JS
    Arq Bras Oftalmol; 2012 Oct; 75(5):324-32. PubMed ID: 23471326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current trends in the management of thyroid eye disease.
    Rao R; MacIntosh PW; Yoon MK; Lefebvre DR
    Curr Opin Ophthalmol; 2015 Nov; 26(6):484-90. PubMed ID: 26397888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital radiotherapy plus three-wall orbital decompression in a patient with rare ocular manifestations of thyroid eye disease: case report.
    Zhang S; Wang Y; Zhong S; Liu X; Huang Y; Fang S; Zhuang A; Li Y; Sun J; Zhou H; Fan X
    BMC Endocr Disord; 2018 Feb; 18(1):7. PubMed ID: 29409479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical and surgical treatment of thyroid eye disease.
    Hall AJH; Topliss DJ
    Intern Med J; 2022 Jan; 52(1):14-20. PubMed ID: 32975863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alemtuzumab-Induced Thyroid Eye Disease: A Comprehensive Case Series and Review of the Literature.
    Nirmalan A; Blecher N; Hyder S; Couch SM; Godfrey KJ; Stan MN; Bradley EA; Wagner LH; Tooley AA
    Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):470-474. PubMed ID: 36893061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.